At the transcriptomic level, both FREM2 and SPRY1 showed differences in expression when analyzed as GBM versus LGG (***, p = 0.0001; ****, p < 0.0001; respectively); i.e., higher gene expression levels in GBM in both cases, as shown in Figure 4. Here, FREM2 is linked to glioblastoma.